O-1 Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial

Z. Wainberg, D. Melisi, T. Macarulla,R. Pazo Cid, S. Chandana,C. de la Fouchardière, A. Dean, I. Kiss,W. Lee, T. Goetze,E. Van Cutsem, S. Paulson, T. Bekaii-Saab, S. Pant, R. Hubner, Z. Xiao,H. Chen, F. Benzaghou, E. O'Reilly

Annals of Oncology（2023）

引用 0|浏览5

暂无评分

关键词

metastatic pancreatic ductal adenocarcinoma,nalirifox,nab-paclitaxel,treatment-naive

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要